NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Medical Officer David Lebwohl sold $379K of Intellia Therapeutics, Inc.
Sold$379,300
$158.04Price
2,400Shares
−75%Stake
What NTLA did after the filing
- The stock from Wed, Sep 1 close, $164.04
- −19.7%
- S&P 500, same days
- −1.7%
Measured over 30 trading days, to the Oct 14 close.
Traded Mon, Aug 30. Filed Wed, Sep 1, 3:32 PM ET, during the session. Returns use the Sep 1 close and the Oct 14 close. Not investment advice.